Plaintiffs suing Merck over its shingles vaccine Zostavax have lost a fight to have their cases heard in state court, after a judge determined one of the defendants had been fraudulently joined.
U.S. District Judge Harvey Bartle of the Eastern District of Pennsylvania on May 26 rejected attempts by 10 plaintiffs to have their cases remanded to the Philadelphia Court of Common Pleas.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
